Skip to main content
SpringerLink
Log in

Comparison of biochemical aromatase activity with aromatase immunhistochemistry in human breast carcinomas

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The role of intratumoural aromatase in human breast cancer growth remains controversial. At the same time as the use of aromatase inhibitors in the clinical setting continues to increase, so does the need for a tool to predict the likely response to this treatment. Intratumoural aromatase is a candidate predictive marker. The presently accepted 'gold standard' methods of assessment of aromatase activity are biochemical assays. However, these are time-consuming and require relatively large amounts of fresh or frozen tissue which are frequently not available. The development of a reliable immunohistochemical technique for the assessment of intratumoural aromatase which could be applied rapidly to more readily available paraffin-embedded material is therefore highly desirable. Unfortunately aromatase immunohistochemistry is also an area of controversy; some authors describe localisation to the stromal compartment but others to the malignant epithelial cells themselves. The aim of this study was therefore to compare immunohistochemical scores using two different antibodies with biochemical aromatase activity. Taking a group of 29 human breast carcinomas we demonstrated a strong correlation between immunoreactivity with a monoclonal antibody (p = 0.01) but not with a polyclonal (p = 0.16). The monoclonal produced reactivity in both epithelial and stromal cells but the polyclonal in only stromal cells. The implications of these results are discussed together with the need for further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. James VHT, Reed MJ: Steroid hormones and human cancer. Prog Cancer Res Ther 14: 471–487, 1980

    CAS  Google Scholar 

  2. Silva MC, Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I, Coombes RC: Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49: 2588–2591, 1989

    PubMed  CAS  Google Scholar 

  3. Thorsen T, Tangen M, Stoa KF: Concentrations of endogenous estradiol as related to estradiol receptor sites in breast tumor cytosol. Eur J Cancer Clin Oncol 18: 333–337, 1982

    Article  PubMed  CAS  Google Scholar 

  4. van Landeghem AAJ, Portman J, Nabauura M: Endogenous concentration and subcellular distribution of estrogens in normal and malignant breast tissue. Cancer Res 45: 2900–2906, 1985

    PubMed  CAS  Google Scholar 

  5. Bradlow HL: A reassessment of the role of breast tumor aromatisation. Cancer Res 42: 3382S–3386S, 1982

    PubMed  CAS  Google Scholar 

  6. Masamura S, Santner SJ, Heitjan DF, Santen RJ: Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80: 2918–2925, 1995

    Article  PubMed  CAS  Google Scholar 

  7. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A: Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinol 137: 3061–3068, 1996

    Article  CAS  Google Scholar 

  8. Miller WR, O'Neill J: The importance of local synthesis of estrogen within the breast. Steroids 50: 537–548, 1987

    Article  PubMed  CAS  Google Scholar 

  9. Miller WR: Importance of intratumoural aromatase, and its susceptibility to inhibitors. In: Dosett M (ed) Aromatase Inhibition — Then, Now and Tomorrow. Parthenon Publishing, New York, 1994, pp 43–53

    Google Scholar 

  10. Bezwoda WR, Mansoor N, Dansey R: Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide. Oncology 44: 345–349, 1987

    Article  PubMed  CAS  Google Scholar 

  11. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Human Pathol 25: 530–535, 1994

    Article  CAS  Google Scholar 

  12. Santen RJ, Martel J, Hoahland F, Naftolin F, Roa L, Harada N, Hafer L, Zaino R, Santner SJ: Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79: 627–632, 1994

    Article  PubMed  CAS  Google Scholar 

  13. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, Chen S: Detection of intratumoral aromatase in breast carcinomas. Am J Pathol 140: 337–343, 1992

    PubMed  CAS  Google Scholar 

  14. Jacobs TW, Prioleau JE, Stillman IE, Scnitt SJ: Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88: 1054–1059, 1996

    PubMed  CAS  Google Scholar 

  15. Mendelson CR, Wright EE, Evans CT, Porter JC, Simpson ER: Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450AROM), and their use in its purification. Arch Biochem Biophys 243: 480–491, 1985

    Article  PubMed  CAS  Google Scholar 

  16. Harada N: Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J Biochem 103: 106–113, 1988

    PubMed  CAS  Google Scholar 

  17. Detre S, Saccani Jotti G, Dowsett M: A ‘quickscore’ method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48: 876–878, 1995

    PubMed  CAS  Google Scholar 

  18. Hartree EF: Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48: 422–427, 1972

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Unit, St. George's Hospital, Blackshaw, Road, London, SW17 0QT

    K.C. Shenton & N.P.M. Sacks

  2. Department of Academic Biochemistry, Royal Marsden Hospital, Fulham Road, London, UK

    M. Dowsett

  3. Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore

    Q. Lu & A. Brodie

  4. Department of Pathology, Tohoku University School of Medicine, Sendai, Japan

    H. Sasano

  5. Institute of Cancer Research, Downs Road, Sutton, Surrey, UK

    M.G. Rowlands

Authors
  1. K.C. Shenton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Dowsett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Q. Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Brodie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Sasano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N.P.M. Sacks
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M.G. Rowlands
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shenton, K., Dowsett, M., Lu, Q. et al. Comparison of biochemical aromatase activity with aromatase immunhistochemistry in human breast carcinomas. Breast Cancer Res Treat 49 (Suppl 1), S101–S107 (1998). https://doi.org/10.1023/A:1006033813899

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006033813899

Search

Navigation